MedPath
HSA Approval

Fenosup Lidose 160mg Capsule

SIN13351P

Fenosup Lidose 160mg Capsule

Fenosup Lidose 160mg Capsule

September 4, 2007

HYPHENS PHARMA PTE. LTD.

HYPHENS PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHYPHENS PHARMA PTE. LTD.
Licence HolderHYPHENS PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

C10AB05

fenofibrate

Manufacturer Information

HYPHENS PHARMA PTE. LTD.

SMB Technology S.A.

Active Ingredients

Fenofibrate

160mg

Fenofibrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fenosup Lidose 160mg Capsule - HSA Approval | MedPath